|
|
|
Cypress Soars 98% on Drug Trial |
| |
Author: Elena Todorova
123jump.com
Last Update: 11:13 AM EDT May 23 2007
Forest Laboratories was a notable gainer on the S&P, rising 5%. The drug maker said that early results from a clinical trial showed the experimental fibromyalgia drug developed with Cypress Biosciences was better than a placebo. Cypress stock skyrocketed 98%. Analog Devices dropped 8.6% after reporting a 14% profit decline and projecting current quarter earnings below expectations. |
|
| |
|
|
